KANTOFF AARON bought AVTX
March 28, 2026 · Form 4 insider transaction
KANTOFF AARON bought 3,166 shares of Avalo Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,166
Price
N/A
Total value
N/A
InsiderKANTOFF AARON
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 28, 2026
Filing dateMarch 31, 2026
Shares owned after6,333
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted stock units convert into common stock on a one-for-one basis.